NCT03850717

Brief Summary

Acupuncture, along with other complementary and integrative treatments, is commonly used as a complementary or integrative therapy when treating a multitude of pain complaints, including chronic low back pain(CLBP). It has been practiced as a non-pharmacological therapy in the United States over one hundred years. Integrative pain management pilot programs have demonstrated impressive reductions in medications use, emergency room visits, and annual costs of healthcare. In fact, CLBP is one of the most common conditions treated in an acupuncturist's daily schedule. Based on acupuncturists' practice, CLBP has accounted for about 12% of patient visits in recent years. Most CLBP patients who come to acupuncturists' clinic are older adults. Investigators will retrospectively check the safety of acupuncture, i.e.side effects or adverse effects of acupuncture during treatments of CLBP in older adults in past 5 years.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 31, 2013

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 20, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 22, 2019

Completed
Last Updated

February 25, 2019

Status Verified

February 1, 2019

Enrollment Period

5 years

First QC Date

February 20, 2019

Last Update Submit

February 21, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • The rate of participates with bleeding

    bruise in 3 levels: diameter\<5mm, 6-10mm, \>11mm

    2013-2018

Secondary Outcomes (4)

  • The rate of participates with pain

    2013-2018

  • The rate of participates with fainting

    2013-2018

  • The rate of participates with organ injury

    2013-2018

  • The rate of participates caused Infection

    2013-2018

Study Arms (2)

Traditional Chinese Acupuncture

Use traditional acupuncture, stronger, deeper, "harder-acupuncture"

Device: acupuncture

Japanese Acupuncture

Use traditional shallow, lighter acupuncture, "softer-acupuncture"

Device: acupuncture

Interventions

insert in filiform needles into skin and other soft tissue to treat the illness or disorders

Japanese AcupunctureTraditional Chinese Acupuncture

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

* age: 65 years or older; * both genders; * white, black and other nationalities. * with chronic low back pain. * Had at least one acupuncture treatment in McLean Center for Complementary and Alternative Medicine, PLC during the period of Dec. 31, 2013 to Dec.30, 2018.

You may qualify if:

  • Age: 65-80 years old.
  • CLBP is defined as a back pain problem that has persisted for at least 3 months or has resulted in pain on at least half the days in the past 6 months.
  • A minimum pain intensity score of 4 out of 10 on a visual analog scale (0 = no pain, 10 = most severe pain);
  • ability of the participant to fully understand the trial procedure and the risks involved, communicate with the examiner, and comply with the protocol;
  • provision of written informed consent for participation.

You may not qualify if:

  • Age: younger than 65.
  • Pain mainly at legs;
  • a history of spinal surgery;
  • hip osteoarthritis; progressive neurological deficit or severe psychiatric or psychological disorders;
  • serious spinal disorders, such as metastatic cancer, vertebral fracture, spinal infection, and inflammatory spondylitis;
  • other contraindications for treatment, such as clotting disorders, use of anticoagulants or chemotherapy medications, and seizure disorders;
  • presence of a device that could be affected by electromagnetic fields, such as a pacemaker;
  • use of medications that could affect the trial results, such as corticosteroids and anticonvulsants, within the last week;
  • participation in other clinical trials;
  • ineligibility judged by a researcher.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

McLean Center for Complementary and Alternative Medicine,PLC

Vienna, Virginia, 22182, United States

Location

Related Publications (2)

  • Fan AY, Ouyang H, Qian X, Wei H, Wang DD, He D, Tian H, Gong C, Matecki A, Alemi SF. Discussions on real-world acupuncture treatments for chronic low-back pain in older adults. J Integr Med. 2019 Mar;17(2):71-76. doi: 10.1016/j.joim.2019.01.005. Epub 2019 Jan 26.

  • Chan MWC, Wu XY, Wu JCY, Wong SYS, Chung VCH. Safety of Acupuncture: Overview of Systematic Reviews. Sci Rep. 2017 Jun 13;7(1):3369. doi: 10.1038/s41598-017-03272-0.

MeSH Terms

Interventions

Acupuncture Therapy

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Arthur Y Fan, MD, PhD, LAc

    McLean Center for Complementary and Alternative Medicine, PLC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 20, 2019

First Posted

February 22, 2019

Study Start

December 31, 2013

Primary Completion

December 30, 2018

Study Completion

February 20, 2019

Last Updated

February 25, 2019

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will not share

protect patients' personal information

Locations